A Randomized, Double-blind, Placebo and Active Comparator Controlled, Parallel Group Thorough QTc Study of Pradigastat in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Pradigastat (Primary)
- Indications Hyperlipoproteinaemia type I
- Focus Adverse reactions; Pharmacokinetics
- 15 Dec 2016 New trial record
- 01 Nov 2016 Results published in the Clinical Pharmacology in Drug Development.